The Bcl-2 Family as a Rational Target for the Treatment of B-Cell Chronic Lymphocytic Leukaemia

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|17|9|801-811

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.17, Iss.9, 2010-03, pp. : 801-811

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Rituximab: A Review of its Use in Chronic Lymphocytic Leukaemia, Low-Grade or Follicular Lymphoma and Diffuse Large B-Cell Lymphoma

By Keating Gillian M.  

Drugs, Vol. 70, Iss. 11, 2010-07 ,pp. : 1445-1476

Adis International

Access to resources Recommend Favorite

New Directions in the Diagnosis and Treatment of Chronic Lymphocytic Leukaemia

By Schriever F.   Huhn D.  

Drugs, Vol. 63, Iss. 10, 2003-01 ,pp. : 953-969

Adis International

Access to resources Recommend Favorite

Management of Chronic Lymphocytic Leukaemia

By Kalil N.   Cheson B.D.  

Drugs & Aging, Vol. 16, Iss. 1, 2000-01 ,pp. : 9-27

Adis International

Access to resources Recommend Favorite

Fludarabine in chronic lymphocytic leukaemia

By Elter Thomas   Hallek Michael   Engert Andreas  

Expert Opinion on Pharmacotherapy, Vol. 7, Iss. 12, 2006-08 ,pp. : 1641-1651

Informa Healthcare

Access to resources Recommend Favorite

Chronic lymphocytic leukaemia

By Singer Charles   Goldstone Tony  

Clinical Medicine, Vol. 1, Iss. 5, 2001-09 ,pp. : 350-353

Royal College Of Physicians

Access to resources Recommend Favorite